Howe Jill Ann has filed 7 insider transactions across 2 companies since March 2024.
Most recent transaction: a grant/award of 1050000 shares of Lineage Cell Therapeutics, Inc. ($LCTX) on March 05, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | Lineage Cell Therapeutics, Inc. | $LCTX | Howe Jill Ann | Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 1050000 | $0.00 | 1,050,000.0000 | 230,328,000 | 9999.99% | 0.46% |
| March 10, 2025 | Lineage Cell Therapeutics, Inc. | $LCTX | Howe Jill Ann | Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 750000 | $0.00 | 750,000.0000 | 220,416,326 | 9999.99% | 0.34% |
| Nov. 26, 2024 | Lineage Cell Therapeutics, Inc. | $LCTX | Howe Jill Ann | Chief Financial Officer | P | Common Shares | 15000 | $0.59 | 25,500.0000 | 174,987,000 | 142.86% | 0.01% |
| Aug. 16, 2024 | Lineage Cell Therapeutics, Inc. | $LCTX | Howe Jill Ann | Chief Financial Officer | P | Common Shares | 10500 | $0.89 | 10,500.0000 | 174,987,000 | 9999.99% | 0.01% |
| June 5, 2024 | BIORA THERAPEUTICS, INC. | $BIORQ | Howe Jill Ann | Not found | A | Common Stock | 12500 | $0.00 | 31,916.0000 | 30,313,428 | 64.38% | 0.04% |
| June 5, 2024 | BIORA THERAPEUTICS, INC. | $BIORQ | Howe Jill Ann | Not found | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 30,313,428 | 9999.99% | 0.04% |
| March 7, 2024 | Lineage Cell Therapeutics, Inc. | $LCTX | Howe Jill Ann | Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 650000 | $0.00 | 650,000.0000 | 174,987,000 | 9999.99% | 0.37% |